Stand out for this role — generate a tailored resume and cover letter in about a minute.
The Lee Kong Chian School of Medicine seeks a Research Associate to support bioinformatics research focused on cancer genomics and cancer screening. The role involves analysing genomic and clinical data and contributing to the development of cancer survival prediction models, with collaboration across an NTU-Imperial partnership environment.
Applicants should hold a Master’s degree in Bioinformatics or related field, have experience in genomic data analysis and statistics, and be proficient in R
The Lee Kong Chian School of Medicine (LKCMedicine) trains doctors who put patients at the centre of their exemplary care. The School, which offers both undergraduate and graduate programmes, is named after local philanthropist Tan Sri Dato Lee Kong Chian. Established in 2010 by Nanyang Technological University, Singapore, in partnership with Imperial College London, LKCMedicine aims to be a model for innovative medical education and a centre for transformative research. The School’s primary clinical partner is the National Healthcare Group, a leader in public healthcare recognised for the quality of its medical expertise, facilities and teaching. The School is transitioning to an NTU medical school ahead of the 2028 successful conclusion of the NTU-Imperial partnership to set up a Joint Medical School. In August 2024, we welcomed our first intake of the NTU MBBS programme, that has been recently enhanced to include themes like precision medicine and Artificial Intelligence (AI) in healthcare, with an expanded scope in the medical humanities. Graduates from the five-year undergraduate medical degree programme will have a strong understanding of the scientific basis of medicine, with an emphasis on technology, data science and the humanities.
We are looking for a Research Associate to support bioinformatics research, with particular focus on cancer genomics and cancer screening at the Lee Kong Chian School of Medicine. The role will focus on analysing genomic and clinical data and supporting the development of cancer survival prediction models.